New artificial pancreas 'a boon for kids under 7'
Researchers have shown improved glycated haemoglobin and acceptable safety using a proprietary app
Closed-loop therapy can greatly improve glycaemic control in very young children with type 1 diabetes without increasing hypoglycaemic episodes, according to a landmark trial.
A hybrid closed-loop insulin delivery system also leads to fewer, and less severe, hyperglycaemic episodes, UK researchers say.
Given the challenges associated with diabetes management in under-sevens, their international team suggest closed-loop control not only may reduce the risk of neurocognitive deficits but also provides additional
